Rising clinical trial activity, biologic breakthroughs, and expansions in gene therapy research are accelerating the generalized myasthenia gravis treatment market, driven by the demand for personalized and effective care. https://www.datamintelligence.com/research-report/generalized-myasthenia-gravis-treatment-market